chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Haematocrit increased, Haemoglobin increased, Hypoxia, Infection, Lung infiltration
Clinical narrative: 75-year-old female presented with nausea, chest tightness, and shortness of breath.  Patient did have some mild fatigue and a mild cough 2 weeks prior.  After getting her flu shot, about 4 hours later, she developed nausea, vomiting, and chest tightness.  This was then followed by progressive shortness of breath with orthopnea.  Upon presentation to the emergency department, patient was found to be in atrial fibrillation with RVR which is new for her.  She was also hypoxic at 87% on room air.  CT angiogram thorax showed no PE but there was bilateral infiltrates, pulmonary edema versus infectious.  Her COVID test came back positive.  She also had significantly elevated troponin at 683 with an elevated BNP at 4000. Patient has been vaccinated for COVID.  Upon discussion with Cardiology, patient was started on a heparin drip and daily aspirin.  Patient was started on Decadron and remdesivir for COVID pneumonia.  Her presentation was thought to be multifactorial cause by pulmonary edema, AFib with RVR, and COVID pneumonia.  Patient was placed on Cardizem drip.  Her symptoms and hypoxia quickly resolved after her rate was controlled.  An echocardiogram showed a decreased ejection fraction of 40% with hypokinetic distal and apical segments.  A cardiac MRI was then done which showed findings consistent with stress-induced cardiomyopathy (apical type).  There was no MRI evidence of myocardial infarction or myocarditis.  Left ventricular ejection fraction was 48%.  Patient was given a dose of Lasix with very good response and urine output.  Follow-up chest x-ray the next day showed improvement of her bilateral infiltrates which points more towards resolving pulmonary edema.  With improvement of her symptoms, patient was discharged home with plans to have a follow-up echocardiogram in 4 weeks.  Patient's metoprolol dose was increased to 75 mg daily.  She was discharged on atorvastatin 40 mg daily, Lasix 20 mg daily, and transition to Eliquis 5 mg twice a day for atrial fibrillation.  She will follow-up with cardiology as an outpatient.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Orthopnoea, Platelet count normal, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: 75-year-old female presented with nausea, chest tightness, and shortness of breath.  Patient did have some mild fatigue and a mild cough 2 weeks prior.  After getting her flu shot, about 4 hours later, she developed nausea, vomiting, and chest tightness.  This was then followed by progressive shortness of breath with orthopnea.  Upon presentation to the emergency department, patient was found to be in atrial fibrillation with RVR which is new for her.  She was also hypoxic at 87% on room air.  CT angiogram thorax showed no PE but there was bilateral infiltrates, pulmonary edema versus infectious.  Her COVID test came back positive.  She also had significantly elevated troponin at 683 with an elevated BNP at 4000. Patient has been vaccinated for COVID.  Upon discussion with Cardiology, patient was started on a heparin drip and daily aspirin.  Patient was started on Decadron and remdesivir for COVID pneumonia.  Her presentation was thought to be multifactorial cause by pulmonary edema, AFib with RVR, and COVID pneumonia.  Patient was placed on Cardizem drip.  Her symptoms and hypoxia quickly resolved after her rate was controlled.  An echocardiogram showed a decreased ejection fraction of 40% with hypokinetic distal and apical segments.  A cardiac MRI was then done which showed findings consistent with stress-induced cardiomyopathy (apical type).  There was no MRI evidence of myocardial infarction or myocarditis.  Left ventricular ejection fraction was 48%.  Patient was given a dose of Lasix with very good response and urine output.  Follow-up chest x-ray the next day showed improvement of her bilateral infiltrates which points more towards resolving pulmonary edema.  With improvement of her symptoms, patient was discharged home with plans to have a follow-up echocardiogram in 4 weeks.  Patient's metoprolol dose was increased to 75 mg daily.  She was discharged on atorvastatin 40 mg daily, Lasix 20 mg daily, and transition to Eliquis 5 mg twice a day for atrial fibrillation.  She will follow-up with cardiology as an outpatient.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Stress cardiomyopathy, Troponin increased, Vomiting, White blood cell count increased
Clinical narrative: 75-year-old female presented with nausea, chest tightness, and shortness of breath.  Patient did have some mild fatigue and a mild cough 2 weeks prior.  After getting her flu shot, about 4 hours later, she developed nausea, vomiting, and chest tightness.  This was then followed by progressive shortness of breath with orthopnea.  Upon presentation to the emergency department, patient was found to be in atrial fibrillation with RVR which is new for her.  She was also hypoxic at 87% on room air.  CT angiogram thorax showed no PE but there was bilateral infiltrates, pulmonary edema versus infectious.  Her COVID test came back positive.  She also had significantly elevated troponin at 683 with an elevated BNP at 4000. Patient has been vaccinated for COVID.  Upon discussion with Cardiology, patient was started on a heparin drip and daily aspirin.  Patient was started on Decadron and remdesivir for COVID pneumonia.  Her presentation was thought to be multifactorial cause by pulmonary edema, AFib with RVR, and COVID pneumonia.  Patient was placed on Cardizem drip.  Her symptoms and hypoxia quickly resolved after her rate was controlled.  An echocardiogram showed a decreased ejection fraction of 40% with hypokinetic distal and apical segments.  A cardiac MRI was then done which showed findings consistent with stress-induced cardiomyopathy (apical type).  There was no MRI evidence of myocardial infarction or myocarditis.  Left ventricular ejection fraction was 48%.  Patient was given a dose of Lasix with very good response and urine output.  Follow-up chest x-ray the next day showed improvement of her bilateral infiltrates which points more towards resolving pulmonary edema.  With improvement of her symptoms, patient was discharged home with plans to have a follow-up echocardiogram in 4 weeks.  Patient's metoprolol dose was increased to 75 mg daily.  She was discharged on atorvastatin 40 mg daily, Lasix 20 mg daily, and transition to Eliquis 5 mg twice a day for atrial fibrillation.  She will follow-up with cardiology as an outpatient.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Contusion, Erythema, Fatigue
Clinical narrative: 3 Hours after receiving vaccine menstrual period appeared again (previous period was 9/23-9/28) and experienced arm pain, fatigue, chills and itching all over body. Approximately on 10/4 or 10/5 arm pain increases followed by swelling, black and blue bruising, redness, and itching. Swelling, itching, redness, and pain extended to elbow. On or around 10/10, joint pain throughout. Difficulty gripping, painful to walk. This lasted a few days. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling. 11/2/21 experiencing sharp shooting pain where the swelling and redness once was lasted a few hours. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Muscular weakness, Pain, Pain in extremity, Paraesthesia
Clinical narrative: 3 Hours after receiving vaccine menstrual period appeared again (previous period was 9/23-9/28) and experienced arm pain, fatigue, chills and itching all over body. Approximately on 10/4 or 10/5 arm pain increases followed by swelling, black and blue bruising, redness, and itching. Swelling, itching, redness, and pain extended to elbow. On or around 10/10, joint pain throughout. Difficulty gripping, painful to walk. This lasted a few days. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling. 11/2/21 experiencing sharp shooting pain where the swelling and redness once was lasted a few hours. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Physical examination, Pruritus, Swelling
Clinical narrative: 3 Hours after receiving vaccine menstrual period appeared again (previous period was 9/23-9/28) and experienced arm pain, fatigue, chills and itching all over body. Approximately on 10/4 or 10/5 arm pain increases followed by swelling, black and blue bruising, redness, and itching. Swelling, itching, redness, and pain extended to elbow. On or around 10/10, joint pain throughout. Difficulty gripping, painful to walk. This lasted a few days. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling. 11/2/21 experiencing sharp shooting pain where the swelling and redness once was lasted a few hours. Sensitivity in the right arm from shoulder to fingers has not dissipated. Still painful to lean on arm. Still experiencing shoulder, elbow joint, wrist, and hand joint pain in right arm. Pins and needle feeling and bruised feeling.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product storage error
Clinical narrative: Patient received vaccine after published expiration date. Moderna Company analyzed vaccine and advised lot 007B21A maintained activity necessary to protect against covid 19 on date vaccine was administered. Also patient did not call in to complain of adverse events. This is administrative error without adverse event.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated for and then tested positive for COVID-19
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 09/28/2021 Break through case of COVID-19 and patient received an antibody infusion to help elevate the effects side effects of COVID-19. Patient is still having breathing issues and Cardiologist indicated that the breathing issue can take up to a year. Patient has history of open-heart surgery.
Age: 72.0
Sex: F
Vaccine: UNK
Symptoms: Rash
Clinical narrative: as before with shot number 2, I have a rash that looks like a hot water scald under my breast across my chest
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: Chills, extreme fatigue, nausea, loss of appetite, headache lasting two days
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, No adverse event
Clinical narrative: PT RECIEVED VACCINE PAST THE BEYOND USE DATE. NO ADVERSE EFFECTS REPORTED.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: After the vaccination I had a mild headache and fatigue. Arm pain where I got the shot. I had an appointment with my doctor, and I told the doctor about the symptoms.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated for and then tested positive for COVID-19
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Intrauterine contraception, Menstruation irregular
Clinical narrative: I have had Mirena IUDs since 2012.  I never have a period when I have the Mirena IUD.  After I received the COVID-19 vaccine, I had a period for the first time in nine years.  I thought maybe it was a one-time event, but since having the COVID-19 vaccine, I have continued to have monthly periods.  This side effect is not going away.  This is extremely unusual for me because I have had Mirena IUDs several times in my adult life, and I NEVER have a period when I have the Mirena IUD, no matter what else has changed in my life.  Since being vaccinated in April 2021, I now have monthly periods.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administration error, Product storage error
Clinical narrative: Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity necessary to protect against covid 19 on date of administration.Also patient did not call in to complain of adverse event. This is administration error without adverse event.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Delivery, Exposure during pregnancy, Foetal growth restriction, HELLP syndrome
Clinical narrative: Patient was 37 weeks pregnant normal pregnancy 10/29: 1330-Patient received .25 ml MODERNA COVID19 booster dose at 1330.  1900- Patient was later induced at OBGYN's request for current diagnosis of Intrauterine growth restriction 2200- Patient received terbutaline at same, time patient's blood pressure rose and sustained with systolic in the 160's. Patient diagnosed with rapid onset of HELLP syndrome and severe preeclampisa 10/30:  0245- infant delivered at 37 weeks and 5 days. APGAR of 9 at time birth. MOC placed on antepartum care.  11/2 - both infant and mom discharged home
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme, Induced labour, Metabolic function test, Pre-eclampsia, Urine albumin/creatinine ratio
Clinical narrative: Patient was 37 weeks pregnant normal pregnancy 10/29: 1330-Patient received .25 ml MODERNA COVID19 booster dose at 1330.  1900- Patient was later induced at OBGYN's request for current diagnosis of Intrauterine growth restriction 2200- Patient received terbutaline at same, time patient's blood pressure rose and sustained with systolic in the 160's. Patient diagnosed with rapid onset of HELLP syndrome and severe preeclampisa 10/30:  0245- infant delivered at 37 weeks and 5 days. APGAR of 9 at time birth. MOC placed on antepartum care.  11/2 - both infant and mom discharged home
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Cough, Dyspnoea, Hypoxia
Clinical narrative: a 79 y.o. female who presented on 10/28/2021 with a 4 day complaint of cough, congestion and shortness of breath and found to be COVID-19 positive (confirmed 10/28/2021), CXR was negative for infiltrates. The patient is vaccinated for COVID 19. She was initially hypoxic in the ED requiring 2L NC but has since been weaned to room air. The patient received treatment with 4 days of remdesivir and decadron. Decadron will be continued upon discharge to complete a total of 10 days of therapy. The patient was planning to discharge back there. However given her COVID-19 positive status she will be returning home until her 10-day quarantine period is complete per the facilities guidelines and will follow-up with the patient at her home. Recommend post-hospital follow-up with PCP in 1-week.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: a 79 y.o. female who presented on 10/28/2021 with a 4 day complaint of cough, congestion and shortness of breath and found to be COVID-19 positive (confirmed 10/28/2021), CXR was negative for infiltrates. The patient is vaccinated for COVID 19. She was initially hypoxic in the ED requiring 2L NC but has since been weaned to room air. The patient received treatment with 4 days of remdesivir and decadron. Decadron will be continued upon discharge to complete a total of 10 days of therapy. The patient was planning to discharge back there. However given her COVID-19 positive status she will be returning home until her 10-day quarantine period is complete per the facilities guidelines and will follow-up with the patient at her home. Recommend post-hospital follow-up with PCP in 1-week.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Myocarditis, Pericarditis, Troponin increased
Clinical narrative: Chest pain. Elevated troponins in ER. Myocarditis or pericarditis.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Balance disorder, Blood test abnormal, Death, Fatigue
Clinical narrative: After the two dosis of Moderna, the patient didn't experience any symptoms. On September 3, 2021, the patient got a third complete dose of Moderna. After this third dose, the patient started feeling extreme fatigue, headaches, and fever.  A week passed by and he wasn't feeling any better, on the contrary, he developed more symptoms like loss of memory and imbalance.  He went to the doctor and had blood tests including a D-dimer test which came high and an MRI which revealed a High-rate Glioblastoma. He later died due to complications of the tumor removal.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Fibrin D dimer increased, Glioblastoma, Headache, Magnetic resonance imaging head abnormal
Clinical narrative: After the two dosis of Moderna, the patient didn't experience any symptoms. On September 3, 2021, the patient got a third complete dose of Moderna. After this third dose, the patient started feeling extreme fatigue, headaches, and fever.  A week passed by and he wasn't feeling any better, on the contrary, he developed more symptoms like loss of memory and imbalance.  He went to the doctor and had blood tests including a D-dimer test which came high and an MRI which revealed a High-rate Glioblastoma. He later died due to complications of the tumor removal.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Procedural complication, Pyrexia, Tumour excision
Clinical narrative: After the two dosis of Moderna, the patient didn't experience any symptoms. On September 3, 2021, the patient got a third complete dose of Moderna. After this third dose, the patient started feeling extreme fatigue, headaches, and fever.  A week passed by and he wasn't feeling any better, on the contrary, he developed more symptoms like loss of memory and imbalance.  He went to the doctor and had blood tests including a D-dimer test which came high and an MRI which revealed a High-rate Glioblastoma. He later died due to complications of the tumor removal.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient is a staff member and received her booster dose during the clinic hosted by pharmacy.  She told clinic staff she completed the initial series at least 6 months ago. She provided a CDC card and the handwritten entry for the 2nd dose appeared to be April 2021. When the team returned to the store to bill and process, it was revealed that the 2nd dose was actually given on 6/21/21 and patient would have been due for booster dose on 12/18/21.  Patient was experiencing no adverse effects at the end of the observation period.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, Chronic spontaneous urticaria, Condition aggravated, Thyroxine normal, Urticaria
Clinical narrative: I have had this in the past. I now have again, Chronic Idiopathic Urticaria now. Chronic hives with an unknown cause. It may have even started on August 1st. It's an immune triggered event, it's linked to inflammatory triggers. I had it in the past for about two years. It's been gone for about six years. I have hives all over my body. I have them in the morning when I wake up and they go away for a little bit in the afternoon and then come back at night at different locations. Treatment is allergy pills, I take Claritin, Zyrtec and Allegra. I take one of those in the morning and one of those in the evening. I also take Famotidine, and I take that every day twice a day.
Age: 44.0
Sex: F
Vaccine: HEP
Symptoms: Fatigue, Injection site erythema, Injection site warmth, Nausea, Pyrexia
Clinical narrative: Fever (99.9), Redness at injection site, warmth, nausea and fatigue. Patient states she feels better today, but the site is still warm and red. Donor is using a cold compress at the area.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Feeling abnormal, Feeling drunk, Immunodeficiency
Clinical narrative: pt states the following day after getting booster shot she developed brain fog.   She felt like she was drunk and disoriented.  She seemed to be having altered perceptions when writing.  She had gone a couple of days of not taking her BP medicine because she was out of them so she refilled her meds and took them which seemed to help with these symptoms.  These symptoms subsided within a few hours.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: PT RECIEVED VACCINE PAST THE BEYOND USE DATE. NO ADVERSE EFFECTS REPORTED.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus
Clinical narrative: Patient developed subjective itching and airway tightness after vaccination.  On physical exam, no airway edema noted or visible rash observed.  Patient was transferred to urgent department for observation given history of allergy to influenza vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The vaccine that was given should have been discarded 12 hours prior. the vial was punctured at 10am on 11/3 and was given to a patient at 9:30am on 11/4
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Discomfort, Dizziness, Dyspnoea, Flushing
Clinical narrative: Patient had a severe allergic reaction after receiving first dose of Moderna vaccine on 10/30/21. Patient reports that she became immediately flushed and dizzy after getting the vaccine. She went home and developed chest pain, shortness of breath, wheezing, lip tingling and felt squeezing pressure that went up her neck and to the right side of her face. She went to urgent care and received solumedrol intramuscular injection and symptoms subsided within 15 minutes.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Immediate post-injection reaction, Paraesthesia oral, Wheezing
Clinical narrative: Patient had a severe allergic reaction after receiving first dose of Moderna vaccine on 10/30/21. Patient reports that she became immediately flushed and dizzy after getting the vaccine. She went home and developed chest pain, shortness of breath, wheezing, lip tingling and felt squeezing pressure that went up her neck and to the right side of her face. She went to urgent care and received solumedrol intramuscular injection and symptoms subsided within 15 minutes.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Blood test, Dyspnoea, Fatigue, Fluid retention
Clinical narrative: It began slowly, after the second dose, once the flu symptom went away, I noticed shortness of breath and my blood pressure issues. I had intense sweating and being fatigue. I was retaining fluid in my ankles, they had me set up for a heart doppler ultrasound. They prescribed me to another blood prescribed Amlodipine Besylate tab once a day, in addition to my other medication. I see my doctor again next week on Wednesday.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Influenza
Clinical narrative: It began slowly, after the second dose, once the flu symptom went away, I noticed shortness of breath and my blood pressure issues. I had intense sweating and being fatigue. I was retaining fluid in my ankles, they had me set up for a heart doppler ultrasound. They prescribed me to another blood prescribed Amlodipine Besylate tab once a day, in addition to my other medication. I see my doctor again next week on Wednesday.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Adenovirus test, Angiogram abnormal, Anticoagulant therapy, Aortic arteriosclerosis
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic dilatation, Arteriosclerosis, Arteriosclerosis coronary artery, Asthenia, Atelectasis
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Atrial flutter, Bacterial test negative, Bacterial test positive, Blood culture negative
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Bordetella test negative, Bronchiolitis, Bronchitis, COVID-19, Cardiac monitoring
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac septal hypertrophy, Cardiac telemetry, Chest X-ray, Chest injury, Chlamydia test negative
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cholelithiasis, Clostridium test, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Coronavirus test negative, Cough, Culture urine positive, Dyspnoea, Dyspnoea exertional
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Echocardiogram abnormal, Ejection fraction normal, Enterococcus test positive, Enterovirus test negative
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Fatigue, Hepatic cirrhosis, Hepatic hypertrophy, Hilar lymphadenopathy
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Human metapneumovirus test, Human rhinovirus test, Inferior vena cava dilatation, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza virus test negative, Left atrial dilatation, Lung opacity, Lymphadenopathy, Lymphadenopathy mediastinal
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Mitral valve calcification, Mitral valve stenosis, Mycoplasma test negative, Nodule, Oedema peripheral
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary granuloma, Pulmonary mass, Pyrexia, Respiratory syncytial virus test negative, Respiratory viral panel
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Right ventricular dilatation, SARS-CoV-2 test positive, Scan with contrast abnormal, Splenomegaly, Stool analysis normal
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Tricuspid valve incompetence, Vascular device user, Viral test
Clinical narrative: Patient is a 79 y.o. male with a PMH of COPD, HLD, hypothyroidism, HTN, DM, and corectal cancer. Patient presented to the ED for generalized weakness and fatigue x 1-2 days.  Stated prior to coming to the ED he had a mechanical fall. + Dry cough that started 1 night PTA.  + SOB, mildly worse than his baseline.  + Conversational dyspnea; patient stated that is his baseline 2/2 to his COPD. + BLE edema; unchanged from baseline per patient.   The patient was admitted for further evaluation and management. He had a positive urine culture for enterococcus. He was initially treated with Rocephin, then Zosyn prior to changing to Amoxicillin 1 g PO TID to complete a 7 day course. The patient was also positive for Covid. He was given dexamethasone in the ED, and Regeneron on 10/29 with subjective improvement in symptoms per patient. Cardiology was consulted for new onset afib. The patient's metoprolol was increased to 100 mg daily and they recommended a Ziopatch which was placed prior to discharge. He was also started on Lovenox during his admission and changed to Eliquis at time of discharge. Prior to discharge, the CM arranged additional services as the patient will be quarantined through 11/11 and lives alone.   The patient was eating and ambulating at the time of discharge. Answered all questions and the patient was comfortable with the discharge plan. Medications as listed below. The patient will follow up with Dr. after his quarantine ends.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: PT RECIEVED VACCINE PAST THE BEYOND USE DATE. NO ADVERSE EFFECTS REPORTED.